Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OY0Q
|
|||
| Drug Name |
Tihotungstate derivative 1
|
|||
| Synonyms |
PMID25553724-Compound-US2011015102237
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Aberrant vascularization [ICD-11: BE2Z] | Patented | [1] | |
| Copper metabolism disorder [ICD-11: 5C64.0; ICD-10: E83.0] | Patented | [1] | ||
| Nervous system disease [ICD-11: 8A00-8E7Z] | Patented | [1] | ||
| Neurodegenerative disorder [ICD-11: 8A20-8A23] | Patented | [1], [2], [3] | ||
| Structure |
 |
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel NF-B inhibitors: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Mar;25(3):319-34. | |||
| REF 2 | VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004. | |||
| REF 3 | Caspase inhibitors: a review of recently patented compounds (2013-2015).Expert Opin Ther Pat. 2018 Jan;28(1):47-59. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.